Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for microcirculation in infection-related acute circulatory failure
ChiCTR-IPR-17011763Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ulinastatin in septic shock and Shock (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Microvascular flow index. Planned start Jul 2017; status: not yet recruiting.
02
Drugs
ulinastatin
03
Conditions
septic shockShock
Beyond the preview
Go deeper on ChiCTR-IPR-17011763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011763.